AEterna Zentaris to Announce Second Quarter 2008 Financial and Operating Results on August 12, 2008



    QUEBEC CITY, Aug. 6 /CNW Telbec/ - AEterna Zentaris Inc. (NASDAQ:   AEZS,
TSX: AEZ), a global biopharmaceutical company focused on endocrine therapy and
oncology, will announce its second quarter 2008 financial and operating
results after market close on Tuesday, August 12, 2008. The Company will host
a conference call and webcast to discuss these results later that same day at
4:30 p.m., Eastern Time.
    Participants may access the conference call by dialing the following
numbers: 416-644-3430, 514-807-8791 or 800-814-4862. They may also access the
live webcast via the Company's website at www.aezsinc.com in the "Investors"
section. A replay of the webcast will also be available on the Company's
website for a period of 30 days.

    About AEterna Zentaris Inc.

    AEterna Zentaris Inc. is a global biopharmaceutical company focused on
endocrine therapy and oncology with proven expertise in drug discovery,
development and commercialization. News releases and additional information
are available at www.aezsinc.com.




For further information:

For further information: Investor Relations: Dennis Turpin, CA, Senior
Vice President and Chief Financial Officer, (908) 626-5503,
dturpin@aezsinc.com; Media Relations: Paul Burroughs, Director of
Communications, (418) 652-8525 ext. 406, pburroughs@aezsinc.com

Organization Profile

Aeterna Zentaris Inc.

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890